Literature DB >> 19502460

Research into acupuncture for respiratory disease in Japan: a systematic review.

Masao Suzuki1, Yoko Yokoyama, Hiroshi Yamazaki.   

Abstract

BACKGROUND: In Japan, studies on acupuncture therapy for respiratory disease have rarely been reported. Additionally, most of the reports are difficult for overseas researchers to access because they are written in Japanese and cannot be located using Medline.
PURPOSE: To review studies on acupuncture and moxibustion therapy for respiratory disease conducted in Japan. DATA SOURCES: The results of a literature search using "Igaku Chuo Zasshi Web" and the Medical Online Library, both of which are Japanese databases, covering the period between 1979 and 2006. STUDY SELECTION: This study reviewed references cited in retrieved documents and selected original articles and case reports on acupuncture and moxibustion therapy for respiratory disease. DATA EXTRACTION: The search terms used were "acupuncture" and "respiratory disease", along with "respiratory", "asthma", "COPD", "bronchitis" and "common cold".
RESULTS: The study retrieved 34 papers on acupuncture treatment for respiratory disease written in Japanese (9 full papers, 19 case reports and 6 case series). The papers dealt with such conditions as asthma (14 trials), cough variant asthma (one trial), chronic obstructive pulmonary disease (seven trials), chronic bronchitis (one trial), usual/idiopathic interstitial pneumonia (one trial) and the common cold (two trials). The study also found eight trials dealing with cold prevention.
CONCLUSIONS: A small number of reports on acupuncture and moxibustion treatment for respiratory diseases were found in the Japanese databases. Future studies must use more rigorous evaluation methods, such as randomised controlled trials, to measure the effectiveness of acupuncture and moxibustion therapy for treating respiratory diseases.

Entities:  

Mesh:

Year:  2009        PMID: 19502460     DOI: 10.1136/aim.2009.000471

Source DB:  PubMed          Journal:  Acupunct Med        ISSN: 0964-5284            Impact factor:   2.267


  6 in total

1.  Factors affecting decision-making of patients choosing acupuncture in a public hospital.

Authors:  Andrew Arjun Sayampanathan; Thean Howe Bryan Koh; Keng He Kong; Yin Peng Low
Journal:  Ann Transl Med       Date:  2015-11

2.  Efficacy of Acupuncture on Quality of Life, Functional Performance, Dyspnea, and Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease: Protocol for a Randomized Clinical Trial.

Authors:  Renato Fleury Cardoso; Ana Cristina Rodrigues Lacerda; Vanessa Pereira Lima; Lucas Fróis Fernandes de Oliveira; Sofia Fróis Fernandes de Oliveira; Rafaela Paula Araújo; Cecylia Leiber Fernandes E Castro; Flávia Pereira da Silva; Lizânia Vieira de Paiva; Lia Dietrich; Pedro Henrique Scheidt Figueiredo; Henrique Silveira Costa; Mario Bernardo-Filho; Danúbia da Cunha de Sá-Caputo; Vanessa Amaral Mendonça; Redha Taiar
Journal:  J Clin Med       Date:  2022-05-28       Impact factor: 4.964

3.  Combination of Acupoints in Treating Patients with Chronic Obstructive Pulmonary Disease: An Apriori Algorithm-Based Association Rule Analysis.

Authors:  Po-Chun Hsieh; Chu-Fang Cheng; Chih-Wei Wu; I-Shiang Tzeng; Chan-Yen Kuo; Pei-Shan Hsu; Chang-Ti Lee; Min-Chien Yu; Chou-Chin Lan
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-20       Impact factor: 2.629

4.  An Improved Apriori Association Rule for the Identification of Acupoints Combination in Treating COVID-19 Patients.

Authors:  Yanyan Zheng
Journal:  Comput Intell Neurosci       Date:  2022-09-06

Review 5.  Space-time acupuncture for intractable cough after lupus nephropathy: A case report and literature review.

Authors:  Taipin Guo; Zukun Chen; Xiantao Tai; Zili Liu; Miansheng Zhu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

6.  Effect of acupuncture on chronic bronchitis: A protocol for systematic review and meta-analysis.

Authors:  Dongdong Mao; Yanli Deng; Leixiao Zhang; Ying Zhao; Ying Li; Fei Wang
Journal:  Medicine (Baltimore)       Date:  2020-06-12       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.